Lam’s New Salzburg AI Packaging Lab Might Change The Case For Investing In Lam Research (LRCX)

Lam Research Corporation

Lam Research Corporation

LRCX

0.00

  • In recent days, Lam Research has drawn fresh attention as multiple analysts upgraded their views and the company opened a new research lab in Salzburg, Austria focused on panel-level chip packaging for AI-related applications.
  • The Salzburg facility’s work on square-panel packaging, which aims to boost chip density and reduce unit costs, positions Lam Research to address manufacturing bottlenecks as AI demand strains global chip capacity.
  • We’ll now examine how Lam’s new Salzburg panel-level packaging lab could influence the company’s existing investment narrative around AI-driven equipment demand.

Capitalize on the AI infrastructure supercycle with our selection of the 44 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

Lam Research Investment Narrative Recap

To own Lam Research, you need to believe AI-driven chip complexity and new manufacturing formats will keep pulling through demand for its etch, deposition, and packaging tools. The Salzburg panel-level packaging lab supports that thesis but does not remove the near term risk that a pause in wafer fab equipment spending or a sudden pullback from a few big customers could hit orders and margins.

The most relevant recent development here is Lam’s raised 2026 wafer fab equipment outlook to US$140 billion and its expectation for advanced packaging revenue to grow more than 50% in 2026. The Salzburg lab plugs directly into that packaging push, potentially reinforcing one of Lam’s key growth engines at a time when investors are weighing strong results and AI exposure against elevated valuation and sector cyclicality.

Yet even with all this AI excitement, investors still need to watch how concentrated Lam’s revenue is with a handful of chipmakers and what happens if...

Lam Research's narrative projects $36.6 billion revenue and $12.3 billion earnings by 2029. This requires 19.0% yearly revenue growth and about a $5.6 billion earnings increase from $6.7 billion today.

Uncover how Lam Research's forecasts yield a $309.52 fair value, a 6% upside to its current price.

Exploring Other Perspectives

LRCX 1-Year Stock Price Chart
LRCX 1-Year Stock Price Chart

Some of the most optimistic analysts were already assuming Lam could lift revenue to about US$41.6 billion by 2029, yet even those bullish views still flagged export controls and China access as meaningful swing factors, so this new Salzburg lab could either strengthen that upside story or force a rethink of how much risk you are really taking on.

Explore 10 other fair value estimates on Lam Research - why the stock might be worth as much as 11% more than the current price!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

  • A great starting point for your Lam Research research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
  • Our free Lam Research research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Lam Research's overall financial health at a glance.

Interested In Other Possibilities?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

  • Find 51 companies with promising cash flow potential yet trading below their fair value.
  • Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
  • The future of work is here. Discover the 32 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.